Search

Wasswa, George. 2014. “A Re-Examination of Race in the U.S.”. Political Science 1 (15).

Mathews, Juanita. 2022. “Ion Channel Drugs Suppress Cancer Phenotype in NG108-15 and U87 Cells: Toward Novel Electroceuticals for Glioblastoma.”

Zhang, Yan-Ling, and Sean P Moran. 2022. “Novel Fluorescence-Based High-Throughput FLIPR Assay Utilizing Membrane-Tethered Genetic Calcium Sensors to Identify T-Type Calcium Channel Modulators.”

Driscoll, Adam. 2020. Lorem Ipsum Dolor Sit Amet, Consectetur Adipiscing Elit, Sed Do Eiusmod Tempor Incididunt Ut Labore et Dolore Magna Aliqua.. Publihser’s Name.

Kamburov, A., M. S. Lawrence, P. Polak, I. Leshchiner, K. Lage, T. R. Golub, E. S. Lander, and G. Getz. 2015. “Comprehensive Assessment of Cancer Missense Mutation Clustering in Protein Structures”. Proc Natl Acad Sci U S A 112: E5486-95.

Kumar, M. S., R. E. Pester, C. Y. Chen, K. Lane, C. Chin, J. Lu, D. G. Kirsch, T. R. Golub, and T. Jacks. 2009. “Dicer1 Functions As a Haploinsufficient Tumor Suppressor”. Genes Dev 23: 2700-4.

Lamb, J., S. Ramaswamy, H. L. Ford, B. Contreras, R. V. Martinez, F. S. Kittrell, C. A. Zahnow, N. Patterson, T. R. Golub, and M. E. Ewen. 2003. “A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer”. Cell 114: 323-34.

Lechman, E. R., B. Gentner, S. W. Ng, E. M. Schoof, P. Galen, J. A. Kennedy, S. Nucera, et al. 2016. “MiR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells”. Cancer Cell 29: 214-28.

Levine, R. L., M. Wadleigh, J. Cools, B. L. Ebert, G. Wernig, B. J. Huntly, T. J. Boggon, et al. 2005. “Activating Mutation in the Tyrosine Kinase JAK2 in Polycythemia Vera, Essential Thrombocythemia, and Myeloid Metaplasia With Myelofibrosis”. Cancer Cell 7: 387-97.

Litichevskiy, L., R. Peckner, J. G. Abelin, J. K. Asiedu, A. L. Creech, J. F. Davis, D. Davison, et al. 2018. “A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations”. Cell Syst 6: 424-443 e7.